AAPL   372.69 (-0.31%)
MSFT   208.25 (-1.16%)
FB   240.86 (+0.24%)
GOOGL   1,489.92 (-0.65%)
AMZN   3,000.12 (-1.86%)
NVDA   394.87 (+0.33%)
CGC   16.50 (-2.60%)
BABA   236.51 (-1.45%)
MU   49.09 (-3.59%)
GE   6.76 (-3.43%)
TSLA   1,389.86 (+1.33%)
AMD   52.93 (-0.88%)
T   30.32 (-0.56%)
ACB   12.42 (+1.97%)
F   6.12 (-1.13%)
GILD   76.42 (-0.44%)
DIS   113.63 (-0.69%)
BAC   23.01 (-2.75%)
NFLX   493.16 (-0.13%)
BA   178.88 (-4.81%)
AAPL   372.69 (-0.31%)
MSFT   208.25 (-1.16%)
FB   240.86 (+0.24%)
GOOGL   1,489.92 (-0.65%)
AMZN   3,000.12 (-1.86%)
NVDA   394.87 (+0.33%)
CGC   16.50 (-2.60%)
BABA   236.51 (-1.45%)
MU   49.09 (-3.59%)
GE   6.76 (-3.43%)
TSLA   1,389.86 (+1.33%)
AMD   52.93 (-0.88%)
T   30.32 (-0.56%)
ACB   12.42 (+1.97%)
F   6.12 (-1.13%)
GILD   76.42 (-0.44%)
DIS   113.63 (-0.69%)
BAC   23.01 (-2.75%)
NFLX   493.16 (-0.13%)
BA   178.88 (-4.81%)
AAPL   372.69 (-0.31%)
MSFT   208.25 (-1.16%)
FB   240.86 (+0.24%)
GOOGL   1,489.92 (-0.65%)
AMZN   3,000.12 (-1.86%)
NVDA   394.87 (+0.33%)
CGC   16.50 (-2.60%)
BABA   236.51 (-1.45%)
MU   49.09 (-3.59%)
GE   6.76 (-3.43%)
TSLA   1,389.86 (+1.33%)
AMD   52.93 (-0.88%)
T   30.32 (-0.56%)
ACB   12.42 (+1.97%)
F   6.12 (-1.13%)
GILD   76.42 (-0.44%)
DIS   113.63 (-0.69%)
BAC   23.01 (-2.75%)
NFLX   493.16 (-0.13%)
BA   178.88 (-4.81%)
AAPL   372.69 (-0.31%)
MSFT   208.25 (-1.16%)
FB   240.86 (+0.24%)
GOOGL   1,489.92 (-0.65%)
AMZN   3,000.12 (-1.86%)
NVDA   394.87 (+0.33%)
CGC   16.50 (-2.60%)
BABA   236.51 (-1.45%)
MU   49.09 (-3.59%)
GE   6.76 (-3.43%)
TSLA   1,389.86 (+1.33%)
AMD   52.93 (-0.88%)
T   30.32 (-0.56%)
ACB   12.42 (+1.97%)
F   6.12 (-1.13%)
GILD   76.42 (-0.44%)
DIS   113.63 (-0.69%)
BAC   23.01 (-2.75%)
NFLX   493.16 (-0.13%)
BA   178.88 (-4.81%)
Log in

NYSE:XYLXylem Stock Price, Forecast & News

$66.08
-1.07 (-1.59 %)
(As of 07/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$65.89
Now: $66.08
$67.61
50-Day Range
$58.19
MA: $65.51
$72.75
52-Week Range
$54.62
Now: $66.08
$89.34
Volume924,600 shs
Average Volume1.45 million shs
Market Capitalization$11.89 billion
P/E Ratio33.21
Dividend Yield1.55%
Beta1.03
Xylem Inc. engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications. It operates in three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation and treatment of water. The Applied Water segment provides pumps, valves, heat exchangers, controls, and dispensing equipment systems under the Goulds Water Technology, Bell & Gossett, A-C Fire Pump, Standard Xchange, Lowara, Jabsco, and Flojet brand names for residential and commercial building services, and industrial water applications. The Measurement & Control Solutions segment provides smart metering, networked communications, and measurement and control technologies, as well as critical infrastructure technologies that allow customers to use their distribution networks for the delivery, monitoring, and control of critical resources, such as water, electricity, and natural gas. It also offers software and services, including cloud-based analytics, remote monitoring, data management, leak detection, and pressure monitoring solutions and testing equipment, as well as sells smart lighting solutions. This segment sells its products under the EmNet, Pure, Sensus, Smith Blair, Valor Water, Visenti, WTW, and YSI brand names. The company markets and sells its products through a network of direct sales force, resellers, distributors, and value-added solution providers in the United States, Europe, the Asia Pacific, and internationally. Xylem Inc. is headquartered in Rye Brook, New York.
Read More
Xylem logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.0Community Rank: 2.5Dividend Strength: 3.3Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.14 out of 5 stars


Industry, Sector and Symbol

Industry Pumps & pumping equipment
Sub-IndustryIndustrial Machinery
CUSIP98419M10
Phone914-323-5700

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$5.25 billion
Cash Flow$5.34 per share
Book Value$16.48 per share

Profitability

Net Income$401 million

Miscellaneous

Employees16,300
Market Cap$11.89 billion
Next Earnings Date7/30/2020 (Confirmed)
OptionableOptionable

Receive XYL News and Ratings via Email

Sign-up to receive the latest news and ratings for XYL and its competitors with MarketBeat's FREE daily newsletter.

Xylem (NYSE:XYL) Frequently Asked Questions

How has Xylem's stock been impacted by COVID-19 (Coronavirus)?

Xylem's stock was trading at $73.24 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, XYL shares have decreased by 9.8% and is now trading at $66.08. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Xylem?

18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Xylem in the last year. There are currently 2 sell ratings, 14 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Xylem.

When is Xylem's next earnings date?

Xylem is scheduled to release its next quarterly earnings announcement on Thursday, July 30th 2020. View our earnings forecast for Xylem.

How were Xylem's earnings last quarter?

Xylem Inc (NYSE:XYL) announced its earnings results on Tuesday, May, 5th. The industrial products company reported $0.23 earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $0.37 by $0.14. The industrial products company had revenue of $1.12 billion for the quarter, compared to the consensus estimate of $1.15 billion. Xylem had a return on equity of 17.08% and a net margin of 7.01%. The business's quarterly revenue was down 9.2% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.52 EPS. View Xylem's earnings history.

How often does Xylem pay dividends? What is the dividend yield for Xylem?

Xylem declared a quarterly dividend on Thursday, May 14th. Investors of record on Thursday, May 28th will be given a dividend of $0.26 per share on Thursday, June 25th. This represents a $1.04 annualized dividend and a dividend yield of 1.57%. The ex-dividend date is Wednesday, May 27th. View Xylem's dividend history.

What price target have analysts set for XYL?

18 brokers have issued 1-year price objectives for Xylem's stock. Their forecasts range from $50.00 to $86.00. On average, they anticipate Xylem's share price to reach $68.08 in the next year. This suggests a possible upside of 3.0% from the stock's current price. View analysts' price targets for Xylem.

Has Xylem been receiving favorable news coverage?

News stories about XYL stock have trended negative on Tuesday, according to InfoTrie Sentiment. The research firm ranks the sentiment of media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Xylem earned a media sentiment score of -2.1 on InfoTrie's scale. They also gave headlines about the industrial products company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news about Xylem.

Are investors shorting Xylem?

Xylem saw a drop in short interest in June. As of June 30th, there was short interest totaling 4,730,000 shares, a drop of 12.2% from the June 15th total of 5,390,000 shares. Based on an average daily volume of 1,370,000 shares, the days-to-cover ratio is presently 3.5 days. Currently, 2.7% of the company's shares are short sold. View Xylem's Current Options Chain.

Who are some of Xylem's key competitors?

What other stocks do shareholders of Xylem own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Xylem investors own include AT&T (T), Verizon Communications (VZ), Walt Disney (DIS), CVS Health (CVS), Intel (INTC), NVIDIA (NVDA), Alibaba Group (BABA), Cisco Systems (CSCO), Mcdonald's (MCD) and AbbVie (ABBV).

Who are Xylem's key executives?

Xylem's management team includes the following people:
  • Mr. Patrick K. Decker, Pres, CEO & Director (Age 54)
  • Mr. E. Mark Rajkowski, Sr. VP & CFO (Age 60)
  • Ms. Claudia S. Toussaint, Sr. VP, Gen. Counsel & Corp. Sec. (Age 55)
  • Mr. Colin R. Sabol, Sr. VP and Pres of Measurement & Control Solutions (Age 51)
  • Mr. Kenneth Napolitano, Sr. VP and Pres of Applied Water Systems & Americas Commercial Team (Age 57)

What is Xylem's stock symbol?

Xylem trades on the New York Stock Exchange (NYSE) under the ticker symbol "XYL."

Who are Xylem's major shareholders?

Xylem's stock is owned by a number of retail and institutional investors. Top institutional investors include Robecosam AG (0.43%), State of Alaska Department of Revenue (0.04%), Renaissance Investment Group LLC (0.03%), Private Asset Management Inc. (0.02%) and S.E.E.D. Planning Group LLC (0.00%). Company insiders that own Xylem stock include Claudia S Toussaint, Colin R Sabol, Curtis J Crawford, Kairus Tarapore, Kenneth Napolitano, Markos I Tambakeras, Pak Steven Leung, Paul A Stellato, Steven R Loranger and Tomas Brannemo. View institutional ownership trends for Xylem.

Which institutional investors are selling Xylem stock?

XYL stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, and Private Asset Management Inc.. Company insiders that have sold Xylem company stock in the last year include Colin R Sabol, Kenneth Napolitano, Markos I Tambakeras, and Pak Steven Leung. View insider buying and selling activity for Xylem.

Which institutional investors are buying Xylem stock?

XYL stock was bought by a variety of institutional investors in the last quarter, including Robecosam AG, Renaissance Investment Group LLC, and S.E.E.D. Planning Group LLC. View insider buying and selling activity for Xylem.

How do I buy shares of Xylem?

Shares of XYL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Xylem's stock price today?

One share of XYL stock can currently be purchased for approximately $66.08.

How big of a company is Xylem?

Xylem has a market capitalization of $11.89 billion and generates $5.25 billion in revenue each year. The industrial products company earns $401 million in net income (profit) each year or $3.02 on an earnings per share basis. Xylem employs 16,300 workers across the globe.

What is Xylem's official website?

The official website for Xylem is www.xyleminc.com.

How can I contact Xylem?

Xylem's mailing address is 1 INTERNATIONAL DRIVE, RYE BROOK NY, 10573. The industrial products company can be reached via phone at 914-323-5700 or via email at [email protected]

This page was last updated on 7/7/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.